The landscape of dementia analysis has advanced substantially with the arrival of refined biomarkers, such as amyloid PET scans, tau imaging, and blood-based assessments that will detect Alzheimer's pathology many years before signs or symptoms emerge. Though these technological advancements signify extraordinary progress in understanding neurodegenerative disorders, they've not dimin... https://karele197clu6.buyoutblog.com/profile